 NEWTON, Mass., July 07, 2021 GLOBE NEWSWIRE -- Allena Pharmaceuticals, Inc. NASDAQ:ALNA, a late-stage biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced the granting of inducement awards to two new employees. In accordance with NASDAQ Listing Rule 5635c4, the awards were made as a material inducement to each employees entry into employment with the Company. 